Puffer & Allgemeine Verbrauchsmaterialien

(R,S)-Anatabine

(R,S)-Anatabine (1,2,3,6-Tetrahydro-2,3'-bipyridine)

(R,S)-Anatabine Bitartrate (2:3)

(R,S)-Anatabine-2,4,5,6-d4

(R,S)-Anatabine-2,4,5,6-d4 (Major)

(R,S)-Carvedilol Glucuronide

(R,S)-Cotinine N-Oxide-methyl-d3

(R,S)-Equol 7-beta-D-Glucuronide Methyl Ester

(R,S)-Lenalidomide, Free Base (3-(4-Amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-piperidinedione, CC-5013, CDC-501, ENMD-0997, Revamid, Revimid)

(R,S)-N-2-(1-Hydroxy-3-butenyl)-L-valinyl-L-leucinyl Anilide ((R,S)-N-2-(1-Hydroxy-3-butenyl)-L-val-L-leu phenylamide)

(R,S)-N-2-(2-Hydroxy-3-butenyl)-L-valinyl-L-leucinyl Anilide ((R,S)-N-2-(2-hydroxy-3-butenyl)-L-val-L-leu phenylamide)

(R,S)-N-Acetyl-S-(2-hydroxy-2-methyl-3-buten-1-yl)-L-cysteine

(R,S)-N-Acetyl-S-(2-hydroxy-2-methyl-3-buten-1-yl)-L-cysteine-d3

(R,S)-N-Acetyl-S-(2-hydroxy-3-methyl-3-buten-1-yl)-L-cysteine + (R,S)-N-Acetyl-S-[1-(hydroxymethyl)-2-methyl-2-propen-1-yl)-L-cysteine (Mixture)

(R,S)-N-Acetyl-S-(2-hydroxy-3-methyl-3-buten-1-yl)-L-cysteine-d3 + (R,S)-N-Acetyl-S-[1-(hydroxymethyl)-2-methyl-2-propen-1-yl)-L-cysteine-d3 (Mixture)

(R,S)-N-Acetyl-S-[1-(hydroxymethyl)-2-propen-1-yl)-L-cysteine + (R,S)-N-Acetyl-S-[2-hydroxy-3-buten-1-yl)-L-cysteine (Approximately 1:1 Mixture)

(R,S)-N-Acetyl-S-[1-(hydroxymethyl)-2-propenyl)-L-cysteine-d6 + (R,S)-N-Acetyl-S-[2-(hydroxymethyl)-3-propenyl)-L-cysteine-d6 Mixture

(R,S)-N-Ethylnorcotinine

Warenkorb

Puffer & Allgemeine Verbrauchsmaterialien

(R,S)-Anabasine-2,4,5,6-d4 ((R,S)-3-(2-Piperidinyl)pyridine-2,4,5,6-d4)

(R,S)-Anatabine

(R,S)-Anatabine (1,2,3,6-Tetrahydro-2,3'-bipyridine)

(R,S)-Anatabine Bitartrate (2:3)

(R,S)-Anatabine-2,4,5,6-d4

(R,S)-Anatabine-2,4,5,6-d4 (Major)

(R,S)-Carvedilol Glucuronide

(R,S)-Cotinine N-Oxide-methyl-d3

(R,S)-Equol 7-beta-D-Glucuronide Methyl Ester

(R,S)-Lenalidomide, Free Base (3-(4-Amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-piperidinedione, CC-5013, CDC-501, ENMD-0997, Revamid, Revimid)

(R,S)-N-2-(1-Hydroxy-3-butenyl)-L-valinyl-L-leucinyl Anilide ((R,S)-N-2-(1-Hydroxy-3-butenyl)-L-val-L-leu phenylamide)

(R,S)-N-2-(2-Hydroxy-3-butenyl)-L-valinyl-L-leucinyl Anilide ((R,S)-N-2-(2-hydroxy-3-butenyl)-L-val-L-leu phenylamide)

(R,S)-N-Acetyl-S-(2-hydroxy-2-methyl-3-buten-1-yl)-L-cysteine

(R,S)-N-Acetyl-S-(2-hydroxy-2-methyl-3-buten-1-yl)-L-cysteine-d3

(R,S)-N-Acetyl-S-(2-hydroxy-3-methyl-3-buten-1-yl)-L-cysteine + (R,S)-N-Acetyl-S-[1-(hydroxymethyl)-2-methyl-2-propen-1-yl)-L-cysteine (Mixture)

(R,S)-N-Acetyl-S-(2-hydroxy-3-methyl-3-buten-1-yl)-L-cysteine-d3 + (R,S)-N-Acetyl-S-[1-(hydroxymethyl)-2-methyl-2-propen-1-yl)-L-cysteine-d3 (Mixture)

(R,S)-N-Acetyl-S-[1-(hydroxymethyl)-2-propen-1-yl)-L-cysteine + (R,S)-N-Acetyl-S-[2-hydroxy-3-buten-1-yl)-L-cysteine (Approximately 1:1 Mixture)

(R,S)-N-Acetyl-S-[1-(hydroxymethyl)-2-propenyl)-L-cysteine-d6 + (R,S)-N-Acetyl-S-[2-(hydroxymethyl)-3-propenyl)-L-cysteine-d6 Mixture

(R,S)-N-Ethylnorcotinine

(R,S)-N-Ethylnornicotine (Homonicotine)